Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Montero is active.

Publication


Featured researches published by A. Montero.


Acta Neurochirurgica | 2000

Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature

A. Montero; J. Romero; Juan A. Vargas; C.A. Regueiro; G. Sánchez-Aloz; F. De Prados; A. De la Torre; G. Aragón

Summary¶ Use of CSF shunt devices is a common practice in neurosurgery, and infection of the shunt is the most frequent complication. In spite of the fact that bacteria are the most widely implicated pathogens, reports of fungal infections, especially due to Candida sp., have increased in recent years. Their reported frequency ranges between 6% and 17%. Many factors have been implicated in the pathogenesis of Candida meningitis, such as broad spectrum antibiotics used in the treatment of a bacterial meningitis, steroids and indwelling bladder and intravenous catheters. The treatment of Candida meningitis still consists of systemic antifungal agents and removal of the shunt.


Reports of Practical Oncology & Radiotherapy | 2012

Radiation techniques used in patients with breast cancer: Results of a survey in Spain

M. Algara; Meritxell Arenas; Dolores De las Peñas Eloisa Bayo; Julia Muñoz; José Antonio Carceller; Juan Salinas; Ferran Moreno; Francisco Martínez; Ezequiel González; A. Montero

AIM To evaluate the resources and techniques used in the irradiation of patients with breast cancer after lumpectomy or mastectomy and the status of implementation of new techniques and therapeutic schedules in our country. BACKGROUND The demand for cancer care has increased among the Spanish population, as long as cancer treatment innovations have proliferated. Radiation therapy in breast cancer has evolved exponentially in recent years with the implementation of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, image guided radiotherapy and hypofractionation. MATERIAL AND METHODS An original survey questionnaire was sent to institutions participating in the SEOR-Mama group (GEORM). In total, the standards of practice in 969 patients with breast cancer after surgery were evaluated. RESULTS The response rate was 70% (28/40 centers). In 98.5% of cases 3D conformal treatment was used. All the institutions employed CT-based planning treatment. Boost was performed in 56.4% of patients: electrons in 59.8%, photons in 23.7% and HDR brachytherapy in 8.8%. Fractionation was standard in 93.1% of patients. Supine position was the most frequent. Only 3 centers used prone position. The common organs of risk delimited were: homolateral lung (80.8%) and heart (80.8%). In 84% histograms were used. An 80.8% of the centers used isocentric technique. In 62.5% asymmetric fields were employed. CTV was delimited in 46.2%, PTV in 65% and both in 38.5%. A 65% of the centers checked with portal films. IMRT and hypofractionation were used in 1% and in 5.5% respectively. CONCLUSION In most of centers, 3D conformal treatment and CT-based planning treatment were used. IMRT and hypofractionation are currently poorly implemented in Spain.


International Journal of Radiation Oncology Biology Physics | 2014

Prognostic Value of External Beam Radiation Therapy in Patients Treated With Surgical Resection and Intraoperative Electron Beam Radiation Therapy for Locally Recurrent Soft Tissue Sarcoma: A Multicentric Long-Term Outcome Analysis

Felipe A. Calvo; Claudio V. Sole; Mauricio Cambeiro; A. Montero; A. Polo; Carmen Gonzalez; Miguel Cuervo; Mikel San Julián; Jose Luis García-Sabrido; Rafael Martínez-Monge

BACKGROUND A joint analysis of data from centers involved in the Spanish Cooperative Initiative for Intraoperative Electron Radiotherapy was performed to investigate long-term outcomes of locally recurrent soft tissue sarcoma (LR-STS) patients treated with a multidisciplinary approach. METHODS AND MATERIALS Patients with a histologic diagnosis of LR-STS (extremity, 43%; trunk wall, 24%; retroperitoneum, 33%) and no distant metastases who underwent radical surgery and intraoperative electron radiation therapy (IOERT; median dose, 12.5 Gy) were considered eligible for participation in this study. In addition, 62% received external beam radiation therapy (EBRT; median dose, 50 Gy). RESULTS From 1986 to 2012, a total of 103 patients from 3 Spanish expert IOERT institutions were analyzed. With a median follow-up of 57 months (range, 2-311 months), 5-year local control (LC) was 60%. The 5-year IORT in-field control, disease-free survival (DFS), and overall survival were 73%, 43%, and 52%, respectively. In the multivariate analysis, no EBRT to treat the LR-STS (P=.02) and microscopically involved margin resection status (P=.04) retained significance in relation to LC. With regard to IORT in-field control, only not delivering EBRT to the LR-STS retained significance in the multivariate analysis (P=.03). CONCLUSION This joint analysis revealed that surgical margin and EBRT affect LC but that, given the high risk of distant metastases, DFS remains modest. Intensified local treatment needs to be further tested in the context of more efficient concurrent, neoadjuvant, and adjuvant systemic therapy.


The Breast | 2014

Accelerated hypofractionated breast radiotherapy: FAQs (frequently asked questions) and facts.

A. Montero; Xavier Sanz; R. Hernanz; Dolores Cabrera; Meritxell Arenas; Eloisa Bayo; Ferran Moreno; Manel Algara

The demand for breast cancer care has increased as cancer treatment innovations have proliferated. Adjuvant radiotherapy to the breast is considered to be part of the standard treatment in breast cancer. The role of radiotherapy in terms of reducing loco-regional recurrence and increased survival after conservative surgery, and also after a mastectomy in selected cases, has been previously shown in several randomized trials. Patterns of radiotherapy commonly used for breast cancer comprise a period of approximately five weeks, frequently with the addition of an additional 1-1.5 weeks of a radiation boost to the primary tumour area. In last years, there has been a renewed interest in hypofractionated and accelerated radiotherapy schedules that reduce the overall treatment time to barely three weeks, leading to an improvement in quality of life for patients and also optimizing workload of radiation oncology departments. However, despite the existing evidence supporting the use of hypofractionated treatment regimens, their widespread is still far from complete. Many questions have generated resistance among clinical oncologists for their regular use. The aim of this review is to answer those questions that may arise with the use of moderate hypofractionation in breast cancer.


Clinical & Translational Oncology | 2010

Cerebellar involvement in Hodgkin's lymphoma: an atypical site of relapse

Aurora Sanz; A. Montero; Clara Salas; Enrique Amaya; Gemma Rodríguez; Rosa Magallón; Alejandro de la Torre

The presentation of intracranial metastases from Hodgkin’s lymphoma is an infrequent event that worsens clinical outcome. A case of Hodgkin’s lymphoma relapse in the cerebellum is described in a 70-year-old woman with a previously treated stage IVA Hodgkin’s lymphoma. Diagnostic workup and treatment strategies for central nervous system relapses are reviewed and discussed. A combination of surgery, radiotherapy and occasionally chemotherapy remains the most appropriate approach to intracranial Hodgkin’s lymphoma.


Strahlentherapie Und Onkologie | 2014

Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity. A multicentric pooled analysis of long-term outcomes

Felipe A. Calvo; Claudio V. Sole; Alfredo Polo; Mauricio Cambeiro; A. Montero; Ana Alvarez; Miguel Cuervo; Mikel San Julián; Rafael Martínez-Monge


Clinical & Translational Oncology | 2009

High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer

A. Montero; R. Hernanz; Ana-Belén Capuz; Eva Fernández; Asunción Hervás; Rafael Colmenares; A. Polo; Sonsoles Sancho; Rafael Molerón; Carmen Vallejo; A. Ramos


Strahlentherapie Und Onkologie | 2014

Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity

Felipe A. Calvo; Claudio V. Sole; Alfredo Polo; Mauricio Cambeiro; A. Montero; Ana Alvarez; Miguel Cuervo; Mikel San Julián; Rafael Martínez-Monge


Clinical & Translational Oncology | 2013

Retreatment with radiotherapy for symptomatic bone, brain or visceral metastases.

R. Hernanz; A. Montero; E. Fernández-Lizarbe; A. Polo; A. Ramos


Clinical & Translational Oncology | 2014

Intraoperative radiotherapy-containing multidisciplinary management of trunk-wall soft-tissue sarcomas.

Claudio V. Sole; Felipe A. Calvo; Mauricio Cambeiro; A. Polo; A. Montero; R. Hernanz; C. Gonzalez; M. Cuervo; D. Perez; Mikel San Julián; Rafael Martínez-Monge

Collaboration


Dive into the A. Montero's collaboration.

Top Co-Authors

Avatar

A. Ramos

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Felipe A. Calvo

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Alfredo Polo

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Claudio V. Sole

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Polo

University of Alcalá

View shared research outputs
Top Co-Authors

Avatar

C.A. Regueiro

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

J. Romero

Autonomous University of Madrid

View shared research outputs
Researchain Logo
Decentralizing Knowledge